| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2997731 | Journal of Vascular Surgery | 2006 | 7 Pages |
Abstract
Treatment with 2500 IU dalteparin subcutaneously given for 3 months after femoropopliteal PTA failed to reduce restenosis/reocclusion at 12 months. However, dalteparin may be beneficial in the subgroup of patients with CLI at 12 months follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Renate MD, Silviana MD, Béatrice R. MD, Thomas MD, Thomas MD, Valentin PhD, Martin MD, Bernd MD,